Enhancing clinically cardiovascular machine learning model for risk prediction via sample augmentation

• by Xiaoyu Tang, Min Tang, Wu Liu, Shaoyang Cui

• June 9, 2026

Soluble fms-like tyrosine kinase-1 and peripartum cardiomyopathy: an exploratory meta-analysis of association and diagnostic performance

• by Triwedya Indra Dewi, William Kamarullah, Hawani Sasmaya Prameswari, Chaerul Achmad, Ruswana Anwar, Delvac Oceandy, Firman Fuad Wirakusumah

• June 8, 2026

A de novo LDLR mutation in severe familial hypercholesterolemia: case report, functional characterization, and a personalized gene correction strategy exploration

• by Shuran Zhang, Wenming Huang, Haoqiang Chen, Ninghui Mu, Le Chang, Baosheng Zhu, Jinman Zhang, Ying Chan

• June 9, 2026

How Quickly Are Patients Reaching Quadruple HFrEF Therapy?

Delays in initiating guideline-directed quadruple therapy may increase early clinical risk in heart failure with reduced ejection fraction.

• by Kathryn Wighton

• June 8, 2026

• 5 min